A Study Of The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis
NCT00375596 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2015-02-20
Summary
This study will evaluate the safety and efficacy of a new allergy medication
Conditions
- Allergic Conjunctivitis
Interventions
- DRUG
-
Ketotifen/vasoconstrictor
Sponsors & Collaborators
-
Bausch & Lomb Incorporated
lead INDUSTRY
Eligibility
- Min Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat
NCT04981717 ·Status: TERMINATED ·Phase: PHASE3
-
Ocular Allergy Treatment Practical Impact Trial
NCT01808768 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis
NCT00550875 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
NCT00574704 ·Status: COMPLETED ·Phase: PHASE2
-
Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies
NCT01307319 ·Status: COMPLETED ·Phase: PHASE3
-
Study Of Perennial Allergic Rhinitis In Pediatrics
NCT00253058 ·Status: COMPLETED ·Phase: PHASE3
-
A Novel Biologic Therapy for Perennial Allergic Rhinitis
NCT03360071 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis
NCT00407927 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis
NCT05265910 ·Status: COMPLETED ·Phase: PHASE4
-
Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis
NCT00331500 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With Cat Dander
NCT04207697 ·Status: COMPLETED
-
Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug
NCT00318747 ·Status: TERMINATED ·Phase: PHASE2
-
Perennial Allergic Rhinitis Study In Pediatric Subjects
NCT00108914 ·Status: COMPLETED ·Phase: PHASE3
-
Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects
NCT02322216 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts
NCT01012752 ·Status: UNKNOWN ·Phase: PHASE3
-
A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine
NCT01103050 ·Status: COMPLETED ·Phase: PHASE2
-
Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis
NCT01159769 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis
NCT04881461 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Study Of S-555739/Cetirizine HCl In Adult Patients With Seasonal Allergic Rhinitis
NCT01651871 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea
NCT02555761 ·Status: COMPLETED
-
A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis
NCT00561717 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM
NCT05395689 ·Status: RECRUITING ·Phase: PHASE3
-
The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo
NCT01471184 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of rEV131 in Allergic Rhinitis
NCT00247520 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis
NCT01160861 ·Status: COMPLETED ·Phase: PHASE1